Literature DB >> 2042594

Prognostic factors in esophageal squamous carcinoma. A study of histologic features, blood group expression, and DNA ploidy.

S S Robey-Cafferty1, A K el-Naggar, A A Sahin, J M Bruner, J Y Ro, K R Cleary.   

Abstract

The authors studied 69 squamous carcinomas of the middle or lower esophagus to evaluate prognostic factors. Clinical and histologic parameters that were evaluated included weight loss, esophageal obstruction at presentation, site, gross configuration, degree of tumor differentiation, vascular invasion, the status of resection margins, and stage. Blood group antigen (BGA) expression in the tumors was determined immunohistochemically and compared with blood type and antigen reactivity in adjacent normal mucosa. A loss of BGA expression was seen in 27 tumors. This finding was correlated with high stage but was not significantly linked to survival. DNA ploidy was determined by flow cytometry of paraffin-embedded tissues. Forty-one of 52 tumors were aneuploid, and 14 had two or more separate aneuploid populations. However, survival was not correlated with ploidy status. The degree of differentiation and stage of the tumors were the only two independently significant prognostic indicators in this study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2042594     DOI: 10.1093/ajcp/95.6.844

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China.

Authors:  Miao-Zhen Qiu; Dong-Sheng Zhang; Dan-Yun Ruan; Hui-Yan Luo; Zhi-Qiang Wang; Zhi-Wei Zhou; Feng-Hua Wang; Yu-Hong Li; Rui-Hua Xu
Journal:  Med Oncol       Date:  2010-11-04       Impact factor: 3.064

2.  The ABO blood group predicts survival in esophageal squamous cell carcinoma in patients who ever smoked: a retrospective study from China.

Authors:  Peng Sun; Cui Chen; Fei Zhang; Xin An; Xiu-Yue Li; Yu-Hong Li; Zhi-Hua Zhu; Feng-Hua Wang
Journal:  Tumour Biol       Date:  2014-04-27

3.  Esophageal squamous cell carcinoma: pathology and prognosis.

Authors:  H Ide; T Nakamura; K Hayashi; T Endo; A Kobayashi; R Eguchi; F Hanyu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

4.  The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer.

Authors:  Fergus Noble; James Hopkins; Nathan Curtis; Jamie J Kelly; Ian S Bailey; James P Byrne; Adrian C Bateman; Andrew R Bateman; Timothy J Underwood
Journal:  Med Oncol       Date:  2013-05-21       Impact factor: 3.064

5.  Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist.

Authors:  Ewen A Griffiths; Susan A Pritchard; Nicholas P Mapstone; Ian M Welch
Journal:  World J Surg Oncol       Date:  2006-11-21       Impact factor: 2.754

6.  Prognostic significance of the pN classification supplemented by vascular invasion for esophageal squamous cell carcinoma.

Authors:  Chong-Mei Zhu; Yi-Hong Ling; Shao-Yan Xi; Rong-Zhen Luo; Jie-Wei Chen; Jing-Ping Yun; Dan Xie; Mu-Yan Cai
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

7.  Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer.

Authors:  O A Khan; J J Fitzgerald; I Soomro; F D Beggs; W E Morgan; J P Duffy
Journal:  Br J Cancer       Date:  2003-05-19       Impact factor: 7.640

8.  Transhiatal esophagectomy in a high volume institution.

Authors:  Andrew R Davies; Matthew J Forshaw; Aadil A Khan; Alia S Noorani; Vanash M Patel; Dirk C Strauss; Robert C Mason
Journal:  World J Surg Oncol       Date:  2008-08-20       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.